多公司称已具备尼帕病毒检测能力

Core Viewpoint - The Nipah virus outbreak in India has prompted several A-share listed companies, including BGI Innovation, Capbio, and Antu Biology, to announce their capabilities in Nipah virus testing, although they have not yet achieved significant revenue from these products [1] Group 1: Company Responses - Antu Biology stated that the demand for its Nipah virus testing products cannot be estimated at this early stage of the outbreak in India, and its overseas market presence is relatively small [1] - Capbio acknowledged its technical capability to detect the Nipah virus, but indicated that commercialization is not yet underway and will require time to implement outside of emergency situations [1]